Tigecycline suppressed mitochondrial functions and metabolism of CML cells and resulted in cell death by via activation of cytochrome-c/ caspase-9/ caspase-3 pathway. Here, CASP9 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.